Diabetes Disparities: Texting to Extend Treatment (DD-TXT)
Не применимо
Завершено
NCT04227379
| Заболевание | Diabetes Mellitus, Type 2 |
|---|
| Фаза | Не применимо |
|---|
| Спонсор | VA Office of Research and Development |
|---|
| Статус | Завершено |
|---|
| Участники | 366 участн. |
|---|
| Вмешательство | Intervention 1- DSMS+, Comparison - DSMS |
|---|
| Дата начала | 30.01.2023 |
|---|
| Дата завершения | 30.04.2025 |
|---|
| Публикация результатов | 1.06.2026 |
|---|
Кратко
One way to help Veterans improve their diabetes control is through the use of technology to help provide information, motivation, and reminders necessary to support diabetes self-management. The study will seek input from diverse groups of Veterans living with diabetes to help develop a new customizable, interactive texting intervention that allows Veterans to choose what kinds of diabetes self-management support they need, and when. This diabetes support will be provided to Veterans through "Annie for Veterans", a VA texting system for self-management support. Patients will be randomized to receive a once-daily standard diabetes self-management texting intervention called DSMS based on standard diabetes self-management education content or a customizable, patient-centered diabetes self-management support intervention with additional features called DSMS Plus (DSMS+) in order to test the comparative effectiveness of these two texting interventions.
Change in HbA1c Percent Time in Control
pre-enrollment, 6 month follow up · percent (%) of time in control
| DSMS | 23.41 ± 34.96 percent (%) of time in control |
|---|
| DSMS+ (DSMS Plus) | 21.61 ± 40.55 percent (%) of time in control |
|---|
| p-value | .6519 |
| Mean Difference (Net) | 1.80 (95% CI -6.05–9.65) |
Change in HbA1c
pre-enrollment, 6 month follow-up · Percentage of glycosylated hemoglobin
| DSMS | -0.36 ± 1.37 Percentage of glycosylated hemoglobin |
|---|
| DSMS+ (DSMS Plus) | -0.40 ± 1.29 Percentage of glycosylated hemoglobin |
|---|
| p-value | .7552 |
| Mean Difference (Net) | .05 (95% CI -.25–.34) |
Открыть в BENITIONS
Открыть на ClinicalTrials.gov
Другие исследования по этому заболеванию
Все исследования
Страница обобщает открытые данные ClinicalTrials.gov. Это не медицинская и не инвестиционная рекомендация. Обратитесь к врачу.